arrow
J

Julie E. Lang

University of Kentucky
H指数:35
被引数:4,823

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Multi-center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System in support of FDA clearance
2023-03-010
PRE
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer
2022-12-0112
OA
Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial
2022-11-0111
OA
Clinical trial design during and beyond the pandemic: the I-SPY COVID trial
2022-01-2013
OA
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial

新辅助T-DM1/帕妥珠单抗和紫杉醇/曲妥珠单抗/帕妥珠单抗治疗HER2乳腺癌的适应性随机I-SPY2试验

2021-11-0542
OAAI